157 related articles for article (PubMed ID: 23234835)
21. The efficacy of mifepristone in the reduction and prevention of olanzapine-induced weight gain in rats.
Beebe KL; Block T; Debattista C; Blasey C; Belanoff JK
Behav Brain Res; 2006 Aug; 171(2):225-9. PubMed ID: 16782211
[TBL] [Abstract][Full Text] [Related]
22. Characterisation of olanzapine-induced weight gain and effect of aripiprazole vs olanzapine on body weight and prolactin secretion in female rats.
Kalinichev M; Rourke C; Daniels AJ; Grizzle MK; Britt CS; Ignar DM; Jones DN
Psychopharmacology (Berl); 2005 Oct; 182(2):220-31. PubMed ID: 16001110
[TBL] [Abstract][Full Text] [Related]
23. An animal model of antipsychotic-induced weight gain.
Arjona AA; Zhang SX; Adamson B; Wurtman RJ
Behav Brain Res; 2004 Jun; 152(1):121-7. PubMed ID: 15135975
[TBL] [Abstract][Full Text] [Related]
24. Effects of sub-chronic antipsychotic drug treatment on body weight and reproductive function in juvenile female rats.
Fell MJ; Neill JC; Rao C; Marshall KM
Psychopharmacology (Berl); 2005 Nov; 182(4):499-507. PubMed ID: 16163524
[TBL] [Abstract][Full Text] [Related]
25. A parametric analysis of olanzapine-induced weight gain in female rats.
Cooper GD; Pickavance LC; Wilding JP; Halford JC; Goudie AJ
Psychopharmacology (Berl); 2005 Aug; 181(1):80-9. PubMed ID: 15778884
[TBL] [Abstract][Full Text] [Related]
26. Hyperphagia and increased meal size are responsible for weight gain in rats treated sub-chronically with olanzapine.
Davoodi N; Kalinichev M; Korneev SA; Clifton PG
Psychopharmacology (Berl); 2009 May; 203(4):693-702. PubMed ID: 19052729
[TBL] [Abstract][Full Text] [Related]
27. Effects of atypical antipsychotic drugs on body weight and food intake in dopamine D2 receptor knockout mice.
Yoon S; Noh JS; Choi SY; Baik JH
Biochem Biophys Res Commun; 2010 Mar; 393(2):235-41. PubMed ID: 20117094
[TBL] [Abstract][Full Text] [Related]
28. Antipsychotic-induced metabolic effects in the female rat: Direct comparison between long-acting injections of risperidone and olanzapine.
Ersland KM; Skrede S; Røst TH; Berge RK; Steen VM
J Psychopharmacol; 2015 Dec; 29(12):1280-9. PubMed ID: 26378122
[TBL] [Abstract][Full Text] [Related]
29. A comparison of the effects of olanzapine and risperidone versus placebo on ghrelin plasma levels.
Roerig JL; Steffen KJ; Mitchell JE; Crosby RD; Gosnell BA
J Clin Psychopharmacol; 2008 Feb; 28(1):21-6. PubMed ID: 18204336
[TBL] [Abstract][Full Text] [Related]
30. Investigation into the influence of a high fat diet on antipsychotic-induced weight gain in female rats.
Fell MJ; Neill JC; Anjum N; Peltola LM; Marshall KM
J Psychopharmacol; 2008 Mar; 22(2):182-6. PubMed ID: 18308803
[TBL] [Abstract][Full Text] [Related]
31. The role of thermogenesis in antipsychotic drug-induced weight gain.
Stefanidis A; Verty AN; Allen AM; Owens NC; Cowley MA; Oldfield BJ
Obesity (Silver Spring); 2009 Jan; 17(1):16-24. PubMed ID: 19107124
[TBL] [Abstract][Full Text] [Related]
32. Effect of olanzapine on body composition and energy expenditure in adults with first-episode psychosis.
Graham KA; Perkins DO; Edwards LJ; Barrier RC; Lieberman JA; Harp JB
Am J Psychiatry; 2005 Jan; 162(1):118-23. PubMed ID: 15625209
[TBL] [Abstract][Full Text] [Related]
33. A role of neuropeptide CART in hyperphagia and weight gain induced by olanzapine treatment in rats.
Nakhate KT; Subhedar NK; Kokare DM
Brain Res; 2018 Sep; 1695():45-52. PubMed ID: 29775565
[TBL] [Abstract][Full Text] [Related]
34. No effects of human ghrelin on cardiac function despite profound effects on body composition in a rat model of heart failure.
Akashi YJ; Palus S; Datta R; Halem H; Taylor JE; Thoene-Reineke C; Dong J; Thum T; Culler MD; Anker SD; Springer J
Int J Cardiol; 2009 Nov; 137(3):267-75. PubMed ID: 18723230
[TBL] [Abstract][Full Text] [Related]
35. Effect of application route of the ghrelin analog BIM-28131 (RM-131) on body weight and body composition in a rat heart failure model.
Palus S; von Haehling S; Doehner W; Datta R; Zhang J; Dong JZ; Culler MD; Anker SD; Springer J
Int J Cardiol; 2013 Oct; 168(3):2369-74. PubMed ID: 23465234
[TBL] [Abstract][Full Text] [Related]
36. Antiobesity action of peripheral exenatide (exendin-4) in rodents: effects on food intake, body weight, metabolic status and side-effect measures.
Mack CM; Moore CX; Jodka CM; Bhavsar S; Wilson JK; Hoyt JA; Roan JL; Vu C; Laugero KD; Parkes DG; Young AA
Int J Obes (Lond); 2006 Sep; 30(9):1332-40. PubMed ID: 16534527
[TBL] [Abstract][Full Text] [Related]
37. Chronic clozapine treatment in female rats does not induce weight gain or metabolic abnormalities but enhances adiposity: implications for animal models of antipsychotic-induced weight gain.
Cooper GD; Harrold JA; Halford JC; Goudie AJ
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):428-36. PubMed ID: 17933447
[TBL] [Abstract][Full Text] [Related]
38. Olanzapine effects on body composition, food preference, glucose metabolism and insulin sensitivity in the rat.
Smith GC; Vickers MH; Shepherd PR
Arch Physiol Biochem; 2011 Oct; 117(4):241-9. PubMed ID: 21671852
[TBL] [Abstract][Full Text] [Related]
39. Effects of prior or concurrent food restriction on amylin-induced changes in body weight and body composition in high-fat-fed female rats.
Roth JD; Hughes H; Coffey T; Maier H; Trevaskis JL; Anderson CM
Am J Physiol Endocrinol Metab; 2007 Oct; 293(4):E1112-7. PubMed ID: 17698985
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of olanzapine-induced weight gain by the retinoid analog AM-80.
Richards M; Chiba S; Ninomiya M; Wakabayasi C; Kunugi H
Pharmacopsychiatry; 2013 Nov; 46(7):267-73. PubMed ID: 24105080
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
